Wave Life Sciences (WVE) Change in Receivables (2014 - 2026)

Wave Life Sciences (WVE) has 9 years of Change in Receivables data on file, last reported at $888000.0 in Q2 2026.

• Quarterly Change in Receivables fell 45.08% year-over-year to $888000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$729000.0 (down 322.94% YoY) and the FY2025 annual result came in at -$146000.0, up 99.26% from the prior year.
• Change in Receivables grew to $888000.0 in Q2 2026, from -$1.3 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $14.1 million in Q4 2023 to a low of -$21.1 million in Q1 2024.
• A 4-year average of $74000.0 and a median of $1.1 million in 2024 frame the typical range for Change in Receivables.
• The widest YoY moves for Change in Receivables: up 749.84% in 2025, down 713.5% in 2025.
• Tracing WVE's Change in Receivables over 4 years: stood at $14.1 million in 2023, then slumped by 89.9% to $1.4 million in 2024, then slumped by 713.5% to -$8.7 million in 2025, then soared by 110.18% to $888000.0 in 2026.
• The last three Change in Receivables figures came in at $888000.0 (Q2 2026), -$1.3 million (Q1 2026), and -$8.7 million (Q4 2025), per Business Quant data.